Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bioventus Return on Tangible Equity 2018-2025 | BVS

Current and historical return on tangible equity values for Bioventus (BVS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Bioventus Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.03B $-0.22B 13.87%
2024-12-31 $-0.03B $-0.23B 14.08%
2024-09-30 $-0.04B $-0.24B 15.87%
2024-06-30 $-0.04B $-0.24B 16.05%
2024-03-31 $-0.02B $-0.26B 8.13%
2023-12-31 $-0.16B $-0.27B 56.47%
2023-09-30 $-0.18B $-0.27B 67.97%
2023-06-30 $-0.28B $-0.28B 76.02%
2023-03-31 $-0.29B $-0.28B 76.32%
2022-12-31 $-0.16B $-0.24B 41.50%
2022-09-30 $-0.13B $-0.69B 31.56%
2022-06-30 $-0.02B $-0.29B 7.79%
2022-03-31 $-0.02B $-0.31B 8.23%
2021-12-31 $0.02B $-0.31B -13.91%
2021-09-30 $0.02B $-0.07B -25.34%
2021-06-30 $0.03B $-0.09B -43.84%
2021-03-31 $0.03B $-0.10B -59.70%
2020-12-31 $0.02B $-0.10B -65.98%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.529B $0.573B
Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.891B 28.47
Zoetis (ZTS) United States $67.311B 25.11
Takeda Pharmaceutical (TAK) Japan $46.297B 9.21
Daiichi Sankyo, - (DSNKY) Japan $45.521B 23.33
BeOne Medicines - (ONC) Cayman Islands $32.397B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.766B 0.00
Summit Therapeutics (SMMT) United States $19.710B 0.00
Merck (MKKGY) Germany $16.653B 12.20
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.437B 11.89
Neurocrine Biosciences (NBIX) United States $13.138B 45.00
Orion OYJ (ORINY) Finland $11.666B 28.12
IPSEN (IPSEY) France $10.323B 0.00
Stevanato Group S.p.A (STVN) Italy $7.420B 45.37
Corcept Therapeutics (CORT) United States $7.326B 59.55
Madrigal Pharmaceuticals (MDGL) United States $6.959B 0.00
Ionis Pharmaceuticals (IONS) United States $6.677B 0.00
Grifols, S.A (GRFS) Spain $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.335B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
Hypermarcas (HYPMY) Brazil $3.034B 19.96
Crinetics Pharmaceuticals (CRNX) United States $2.853B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.574B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.549B 8.93
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
Centessa Pharmaceuticals (CNTA) United Kingdom $2.160B 0.00
Ocular Therapeutix (OCUL) United States $1.840B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.810B 0.00
ARS Pharmaceuticals (SPRY) United States $1.728B 0.00
Endo (NDOI) United States $1.603B 0.00
Harrow (HROW) United States $1.325B 0.00
Evotec AG (EVO) Germany $1.321B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.200B 24.00
Avadel Pharmaceuticals (AVDL) Ireland $1.086B 0.00
Ardelyx (ARDX) United States $1.059B 0.00
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.047B 0.00
Collegium Pharmaceutical (COLL) United States $1.017B 5.48
Akebia Therapeutics (AKBA) United States $1.011B 0.00
Verve Therapeutics (VERV) United States $0.988B 0.00
ProKidney (PROK) United States $0.893B 0.00
Cronos Group (CRON) Canada $0.825B 0.00
Xeris Biopharma Holdings (XERS) United States $0.801B 0.00
KalVista Pharmaceuticals (KALV) United States $0.790B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.702B 0.00
Xencor (XNCR) United States $0.655B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Zevra Therapeutics (ZVRA) United States $0.633B 0.00
Organogenesis (ORGO) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.589B 0.00
USANA Health Sciences (USNA) United States $0.587B 11.81
Theravance Biopharma (TBPH) United States $0.562B 0.00
Oruka Therapeutics (ORKA) United States $0.526B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.484B 0.00
Savara (SVRA) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 9.69
Altimmune (ALT) United States $0.341B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
AleAnna (ANNA) United States $0.307B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.37
OmniAb (OABI) United States $0.252B 0.00
Esperion Therapeutics (ESPR) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.240B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
China SXT Pharmaceuticals (SXTC) China $0.204B 0.00
Galectin Therapeutics (GALT) United States $0.181B 0.00
Profound Medical (PROF) Canada $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.175B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Lyell Immunopharma (LYEL) United States $0.152B 0.00
Liminatus Pharma (LIMN) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.143B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Cassava Sciences (SAVA) United States $0.125B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.83
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Nutriband (NTRB) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Fractyl Health (GUTS) United States $0.091B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.074B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.78
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.026B 0.00
Incannex Healthcare (IXHL) Australia $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.41
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.46
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00